Carvalho, Andre F.

The role of high-density lipoprotein cholesterol, apolipoprotein A and paraoxonase-1 in the pathophysiology of neuroprogressive disorders

Morris, G., Puri, B. K., Bortolasci, C. C., Carvalho, A., Berk, M., Walder, K., Moreira, E. G., & Maes, M. (2021) · Neuroscience & Biobehavioral Reviews

Paraoxonase enzyme and polymorphismsCholesterol and Lipid Metabolism

Cited by 84

Association between depression and smoking: a global perspective from 48 low- and middle-income countries

Stubbs, B., Vancampfort, D., Firth, J., Solmi, M., Siddiqi, N., Smith, L., Carvalho, A. F., & Koyanagi, A. (2018) · Journal of Psychiatric Research

Smoking Behavior and CessationMental Health Treatment and Access

Cited by 82

The impact of pharmacological and non-pharmacological interventions on physical health outcomes in people with mood disorders across the lifespan: an umbrella review of the evidence from randomised controlled trials

Croatto, G., Vancampfort, D., Miola, A., Olivola, M., Fiedorowicz, J. G., Firth, J., Alexinschi, O., Gaina, M. A., Makkai, V., Soares, F. C., et al. (2023) · Molecular Psychiatry

Bipolar Disorder and TreatmentTreatment of Major Depression

Cited by 66

The prevalence and clinical characteristics associated with Diagnostic and Statistical Manual Version-5-defined anxious distress specifier in adults with major depressive disorder: results from the International Mood Disorders Collaborative Project

McIntyre, R. S., Woldeyohannes, H. O., Soczynska, J. K., Vinberg, M., Cha, D. S., Lee, Y., Gallaugher, L. A., Dale, R. S., Alsuwaidan, M. T., Mansur, R. B., et al. (2016) · Therapeutic Advances in Chronic Disease

Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 63

Towards a “Metabolic” Subtype of Major Depressive Disorder: Shared Pathophysiological Mechanisms May Contribute to Cognitive Dysfunction

Liu, C., Carvalho, A., & McIntyre, R. (2015) · CNS & Neurological Disorders - Drug Targets

Treatment of Major DepressionTryptophan and brain disorders

Cited by 61

Relative effectiveness of augmentation treatments for treatment-resistant depression: a systematic review and network meta-analysis

Carter, B., Strawbridge, R., Husain, M. I., Jones, B. D. M., Short, R., Cleare, A. J., Tsapekos, D., Patrick, F., Marwood, L., Taylor, R. W., et al. (2020) · International Review of Psychiatry

Treatment of Major DepressionElectroconvulsive Therapy Studies

Cited by 47

The role of meta-analyses and umbrella reviews in assessing the harms of psychotropic medications: beyond qualitative synthesis.

Solmi, M., Correll, C. U., Carvalho, A. F., & Ioannidis, J. P. A. (2018) · Epidemiology and Psychiatric Sciences

Meta-analysis and systematic reviewsPharmaceutical industry and healthcare

Cited by 44

Statins: Neurobiological underpinnings and mechanisms in mood disorders

Walker, A. J., Kim, Y., Borissiouk, I., Rehder, R., Dodd, S., Morris, G., Nierenberg, A. A., Maes, M., Fernandes, B. S., Dean, O. M., et al. (2021) · Neuroscience & Biobehavioral Reviews

Treatment of Major DepressionTryptophan and brain disorders

Cited by 33

Peripheral Blood Biomarkers Coupled with the Apolipoprotein E4 Genotype Are Strongly Associated with Semantic and Episodic Memory Impairments in Elderly Subjects with Amnestic Mild Cognitive Impairment and Alzheimer’s Disease

Supasitthumrong, T., Tunvirachaisakul, C., Aniwattanapong, D., Tangwongchai, S., Chuchuen, P., Tawankanjanachot, I., Snabboon, T., Hemrungrojn, S., Carvalho, A. F., & Maes, M. (2019) · Journal of Alzheimer’s Disease

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 13

The endocannabinoid system in social anxiety disorder: from pathophysiology to novel therapeutics

Ahmed, M., Boileau, I., Le Foll, B., Carvalho, A. F., & Kloiber, S. (2022) · Brazilian Journal of Psychiatry

Cannabis and Cannabinoid ResearchAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 11